๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Otsuka Pharmaceutical Netherlands B.V. โ€” Licensed Medicines

30 medicines held by Otsuka Pharmaceutical Netherlands B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 30 products held by Otsuka Pharmaceutical Netherlands B.V.
MedicineActive substanceLicence holderStatus
Abilify 1 mg/mL oral solution
EU/1/04/276/033-035
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 10 mg orodispersible tablets
EU/1/04/276/024-026
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 10 mg tablets
EU/1/04/276/006-010
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 15 mg orodispersible tablets
EU/1/04/276/027-029
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 15 mg tablets
EU/1/04/276/011-015
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 30 mg orodispersible tablets
EU/1/04/276/030-032
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 30 mg tablets
EU/1/04/276/016-020
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 5 mg tablets
EU/1/04/276/001-005
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify 7.5 mg/mL solution for injection
EU/1/04/276/036
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection
EU/1/13/882/001,003
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection
EU/1/13/882/002,004
Aripiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe
EU/1/13/882/009
Aripiprazole Monohydrate Otsuka Pharmaceutical Netherlands B.V. โ€”
Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe
EU/1/13/882/010
Aripiprazole Monohydrate Otsuka Pharmaceutical Netherlands B.V. โ€”
Dawnzera 80mg solution for injection in pre-filled pen
EU/1/25/2001/001-002
Donidalorsen sodium Otsuka Pharmaceutical Netherlands B.V. โ€”
Inaqovi 35 mg/100 mg film-coated tablets
EU/1/23/1756/001
Decitabine, Cedazuridine Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 15 mg tablets
EU/1/15/1000/001-002
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 15 mg tablets + Jinarc 45 mg tablets
EU/1/15/1000/005-007
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 30 mg tablets
EU/1/15/1000/003-004
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 30 mg tablets + Jinarc 60 mg tablets
EU/1/15/1000/008-010
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Jinarc 30 mg tablets + Jinarc 90 mg tablets
EU/1/15/1000/011-013
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Lupkynis 7.9 mg soft capsules
EU/1/22/1678/001
Voclosporin Otsuka Pharmaceutical Netherlands B.V. โ€”
RXULTI 0.25 mg Film-coated tablet
EU/1/18/1294/001
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
RXULTI 0.5 mg Film-coated tablet
EU/1/18/1294/002
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
RXULTI 1 mg Film-coated tablet
EU/1/18/1294/003-004
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
RXULTI 2 mg Film-coated tablet
EU/1/18/1294/005
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
RXULTI 3 mg Film-coated tablet
EU/1/18/1294/006
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
RXULTI 4 mg Film-coated tablet
EU/1/18/1294/007
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V. โ€”
Samsca 15 mg Tablet
EU/1/09/539/1-2
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Samsca 30 mg Tablet
EU/1/09/539/3-4
Tolvaptan Otsuka Pharmaceutical Netherlands B.V. โ€”
Samsca 7.5 mg Tablet
EU/1/09/539/005-006
Tolvaptan (opc-41061) Otsuka Pharmaceutical Netherlands B.V. โ€”

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.